Delivery Order SPE2DB25D3008-SPE2DB25FRDEN
Award Date 9/8/25
Potential Completion Date 9/9/25
Potential Value $4.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Actemra 162 mg/0.9 mL syringes valued at $11,411.43 under a firm fixed-price contract. The delivery order is non-set-aside and carries an ultimate completion date of September 4, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a $2,611.19 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of ACTEMRA 162 mg/0.9 mL syringes. This contract represents a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and carries no set-aside designation, indicating it was competitively awarded. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order operates under...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Actemra 162 mg/0.9 mL syringes valued at $5,606.23 with firm fixed pricing. This non-competitive delivery order is expected to be completed by August 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of the federal government's reliance on AmerisourceBergen as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $7,194.60 to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed price delivery order, which was competitively awarded without set-aside designation, will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. Actemra is a biologic immunosuppressant medication commonly used in the treatment...
- The Defense Logistics Agency awarded a delivery order valued at $3,386.42 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Actemra 400 mg/20 ml vials. This firm fixed-price delivery order is scheduled for completion by September 2, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Actemra 162 mg/0.9 mL syringes valued at $11,094.37. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of August 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a task under...
- The Defense Logistics Agency awarded a delivery order valued at $3,328.29 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Actemra 162 mg/0.9 ml syringes. This firm fixed-price delivery order is scheduled for completion by July 31, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a $3,729.39 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Actemra 200 mg/10 mL vials. The contract, which is a firm fixed price delivery order with an ultimate completion date of August 20, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). This award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $2,158.38 to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes. The contract, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Actemra 400 mg/20 mL vials with a ceiling value of $6,595.84. This non-set-aside contract award was competitively procured on a firm fixed-price basis, with an ultimate completion date of August 19, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...